ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 37 filers reported holding ALIGOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,775 | -23.1% | 97,423 | 0.0% | 0.00% | – |
| Q2 2023 | $94,598 | +11.1% | 97,423 | 0.0% | 0.00% | – |
| Q1 2023 | $85,148 | -26.5% | 97,423 | -19.9% | 0.00% | – |
| Q4 2022 | $115,916 | +73.0% | 121,646 | +100.0% | 0.00% | – |
| Q3 2022 | $67,000 | -9.5% | 60,823 | 0.0% | 0.00% | – |
| Q2 2022 | $74,000 | -91.5% | 60,823 | -85.0% | 0.00% | – |
| Q1 2022 | $870,000 | -81.2% | 404,756 | +3.8% | 0.00% | – |
| Q4 2021 | $4,630,000 | -20.2% | 390,037 | +4.2% | 0.00% | – |
| Q3 2021 | $5,804,000 | -4.6% | 374,232 | +25.3% | 0.00% | – |
| Q2 2021 | $6,087,000 | +55.5% | 298,587 | +73.5% | 0.00% | – |
| Q1 2021 | $3,914,000 | -11.5% | 172,140 | +7.6% | 0.00% | – |
| Q4 2020 | $4,422,000 | – | 159,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $1,733,325 | 0.92% |
| TANG CAPITAL MANAGEMENT LLC | 3,329,048 | $2,486,799 | 0.35% |
| Vivo Capital, LLC | 3,547,030 | $2,649,631 | 0.29% |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $555,182 | 0.22% |
| Newtyn Management, LLC | 920,000 | $687,240 | 0.17% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 631,887 | $472,020 | 0.14% |
| EcoR1 Capital, LLC | 3,948,360 | $2,949,425 | 0.10% |
| HHLR ADVISORS, LTD. | 2,309,764 | $1,725,394 | 0.04% |
| Baker Brothers Advisors | 2,076,400 | $1,551,071 | 0.01% |
| HARBOURVEST PARTNERS LLC | 18,783 | $14,031 | 0.01% |